|Awarded On||February 16, 2022|
|Title||Leveraging Texas C-STEP's Robust Rural Partnerships for Successful Expansion of its Proven Colorectal Cancer Screening Program to Include HCV Screening|
|Award Mechanism||Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations|
|Institution/Organization||Texas A&M University System Health Science Center|
|Principal Investigator/Program Director||Jason McKnight|
|Cancer Sites||Colorectal, Gallbladder, Liver and Intrahepatic Bile Duct|
Need: Colorectal cancer (CRC), 2nd leading cause of cancer-related death in the US & TX (TX: At a Glance, ACS, 2020), has higher incidence and mortality in rural areas (Zhand et al., 2017), where poor access to healthcare may exist. TX is 47th among states in CRC screening (Joseph et al., 2018), with Hispanics lacking up to date screening (CRC in TX Web Report, TX DSHS, 2019), and black males disproportionately impacted by CRC (TX Cancer Registry). CRC screening is poor among the uninsured (Henley et al., 2020). TX has the highest age-adjusted incidence rate of hepatocellular (liver) cancer (HCC) (ACS, n.d.). HCC prevention includes risk factor assessment and testing for Hepatitis C (HepC), ...